Effect of 2% meloxicam injection in Holstein dairy cows on acute clinical mastitis without systemic symptoms

  • HISAEDA Keiichi
    Department of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • NOHARA Masakatsu
    Department of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • OHTA Naomi
    Department of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • GOTO Akira
    Department of Veterinary Medicine, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • INOUE Yoichi
    Department of Veterinary Medicine, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • HATA Akihisa
    Department of Veterinary Associated Science, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
  • SHINOZUKA Yasunori
    Department of Veterinary Medicine, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan

抄録

<p>This study aimed the efficacy of meloxicam (MX) in treating acute clinical mastitis (ACM) without systemic symptoms in Holstein cows by studying improvement in udder pain, changes in prostaglandin E2(PGE2) and bradykinin (BK) levels in the milk, and milk yield (MY) after healing. Forty-two cows with ACM were randomly assigned to the MX treatment group (T group; n=21) and the control group (C group; n=21). At onset of illness (day 0), the T group received a 0.5 mg/kg subcutaneous (SC) injection of MX whereas the C group received 15 mL SC of saline solution as a placebo. Udder tenderness (UT) was measured, and milk samples were collected on days 0–3. There was little change in the MY of the T group before and after healing, whereas MY in the C group was significantly lower than after healing. UT on day 3 in the T group was significantly lower than that in the C group. PGE2 levels significantly decreased from day 0 to day 3 in both groups. A significant negative correlation between PGE2 and linear score was observed on day 1 in the T group, but not in the C group. In ACM without systemic symptoms, the administration MX may be useful for restoring MY and reducing udder pain after healing.</p>

収録刊行物

参考文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ